IRFI
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
13/03/2026
Voltar para busca
Dado oficial do USPTO
TAURPACK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
14/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
01/11/2018
Data de registro
19/10/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/10/2021
Última transação
14/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH-4002 Basel, CH
Examinador
ABRAMS, JACQUELINE WILLETTE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Novartis AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
30/03/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
30/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
19/10/2021
GPNX
NOTIFICATION PROCESSED BY IB
07/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2021
PUBO
PUBLISHED FOR OPPOSITION
03/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/07/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/07/2021
MREI
NOTICE OF REINSTATEMENT E-MAILED
02/07/2021
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
01/07/2021
REIN
REINSTATED
29/06/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
25/09/2020
DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
30/05/2019
DETH
DEATH OF INTERNATIONAL REGISTRATION
29/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2019
PUBO
PUBLISHED FOR OPPOSITION
02/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2019
ALIE
ASSIGNED TO LIE
18/02/2019
RFNT
REFUSAL PROCESSED BY IB
15/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/02/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/01/2019
RFRR
REFUSAL PROCESSED BY MPU
18/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2019
CNRT
NON-FINAL ACTION WRITTEN
07/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/01/2019
DOCK
ASSIGNED TO EXAMINER
31/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/12/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/12/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
20/12/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TAURPACK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.